Skip to Main Content

Paper Details

A novel BH3-mimetic, AZD0466, targeting BCL-XL and BCL-2 is effective in pre-clinical models of malignant pleural mesothelioma.
Cell Death Discov
23
2021
Author NameAffiliation
Marzena WalkiewiczOlivia Newton-John Cancer Research Institute
John M MariadasonOlivia Newton-John Cancer Research Institute
John M MariadasonLa Trobe University
Jonathan CebonOlivia Newton-John Cancer Research Institute
Jonathan CebonLa Trobe University
Jonathan Cebon
Justin CidadoOncology R&D
Thomas JohnOlivia Newton-John Cancer Research Institute
Thomas JohnLa Trobe University
Thomas John
Thomas JohnPeter MacCallum Cancer Centre
  • 1 - 11

Datasets

Release 1.2